GB2405094B - Pharmaceutical composition for controlled drug delivery system - Google Patents

Pharmaceutical composition for controlled drug delivery system

Info

Publication number
GB2405094B
GB2405094B GB0426726A GB0426726A GB2405094B GB 2405094 B GB2405094 B GB 2405094B GB 0426726 A GB0426726 A GB 0426726A GB 0426726 A GB0426726 A GB 0426726A GB 2405094 B GB2405094 B GB 2405094B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
delivery system
drug delivery
controlled drug
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0426726A
Other versions
GB2405094A (en
GB0426726D0 (en
Inventor
Bharat Pravinchandra Mehta
Madhukant Mansukhlal Doshi
Milind Dattatraya Joshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JB Chemicals and Pharmaceuticals Ltd
Original Assignee
JB Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JB Chemicals and Pharmaceuticals Ltd filed Critical JB Chemicals and Pharmaceuticals Ltd
Priority claimed from PCT/IN2002/000133 external-priority patent/WO2003101431A1/en
Publication of GB0426726D0 publication Critical patent/GB0426726D0/en
Publication of GB2405094A publication Critical patent/GB2405094A/en
Application granted granted Critical
Publication of GB2405094B publication Critical patent/GB2405094B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
GB0426726A 2002-06-04 2002-06-14 Pharmaceutical composition for controlled drug delivery system Expired - Fee Related GB2405094B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN495MU2002 2002-06-04
PCT/IN2002/000133 WO2003101431A1 (en) 2002-06-04 2002-06-14 Pharmaceutical composition for controlled drug delivery system

Publications (3)

Publication Number Publication Date
GB0426726D0 GB0426726D0 (en) 2005-01-12
GB2405094A GB2405094A (en) 2005-02-23
GB2405094B true GB2405094B (en) 2006-06-07

Family

ID=34074055

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0426726A Expired - Fee Related GB2405094B (en) 2002-06-04 2002-06-14 Pharmaceutical composition for controlled drug delivery system

Country Status (5)

Country Link
AU (1) AU2002319898A1 (en)
CA (1) CA2486794A1 (en)
CZ (1) CZ20041175A3 (en)
DE (1) DE10297745T5 (en)
GB (1) GB2405094B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011051308A1 (en) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Manufacturing process and dosage form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865849A (en) * 1987-01-13 1989-09-12 Pharmidea Tablet for pharmaceutical use able to release active substances at successive times
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
WO2003011255A1 (en) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
WO2003097018A1 (en) * 2002-02-04 2003-11-27 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865849A (en) * 1987-01-13 1989-09-12 Pharmidea Tablet for pharmaceutical use able to release active substances at successive times
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
WO2003011255A1 (en) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
WO2003097018A1 (en) * 2002-02-04 2003-11-27 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release

Also Published As

Publication number Publication date
CZ20041175A3 (en) 2005-04-13
GB2405094A (en) 2005-02-23
AU2002319898A1 (en) 2003-12-19
GB0426726D0 (en) 2005-01-12
DE10297745T5 (en) 2006-03-02
CA2486794A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
GB2421689B (en) Drug delivery system
AU2003245368A1 (en) Delivery system for flowable medicinal or therapeutic substances
PL1631255T3 (en) Drug delivery system
PL372323A1 (en) Implantable drug delivery system
PL376169A1 (en) Drug delivery system
AU2003299849A8 (en) Drug delivery apparatus
HUP0203102A3 (en) Bioadhesive drug delivery system
IL174396A0 (en) Oral drug delivery system
IL152573A0 (en) Transdermal delivery system for anti-emetic medication
AU2003259102A1 (en) Injectable system for controlled drug delivery
IL169083A (en) Medication administration system
EP1667619A4 (en) Pharmaceutical delivery system
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
AU2003212962A8 (en) Transdermal drug delivery systems
AU2003241134A1 (en) Transdermal drug delivery system
AU2003231919A8 (en) Oral controlled drug delivery system containing carbamazepine
AU2003275006A8 (en) Aerosol drug delivery system employing formulation pre-heating
AU2003269744A8 (en) Oral osmotic controlled drug delivery system
AU2003285550A1 (en) Drug delivery system
GB2405094B (en) Pharmaceutical composition for controlled drug delivery system
ZA200204331B (en) Pharmaceutical composition for controlled drug delivery system.
IL163614A0 (en) System for transvaginal drug delivery
EG23187A (en) Innovative oral drug delivery system for insulin.
TWI350189B (en) Implantable drug delivery system
AU2002240816A1 (en) Compliance system for drug delivery

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20080614